The advertisement promotes Jardiance (empagliflozin) tablets as a treatment option for chronic kidney disease (CKD), highlighting its use according to KDIGO guidelines and its benefits in reducing risks associated with CKD.
Creative Information
| CID: | 84cfe06f-2b33-4add-9b10-b2494621b29b |
| CRID: | 25_8pbn4skb |
| Domain: | insightsinipf.com |
| Seat: | TTD |
| Size: | 300x250 |
| Bid: | $0.85 |
| Timestamp: | 11/1/2025, 3:11:07 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/12/2025, 3:48:38 PM | 6.66s | |
| adomain_analysis | success | 11/12/2025, 4:55:22 PM | 4.39s | |
| adomain_capture | success | 11/12/2025, 4:53:09 PM | 0.14s | |
| ad_render | success | 11/12/2025, 3:48:31 PM | 24.50s | |
| brand_mapping | success | 11/12/2025, 3:48:15 PM | 7.42s | |
Analysis Results
Ad Format: banner
Brands:
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1606.42 KB | ||||||||||||||||||||||
| Render Time: | 8.97 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1606.76 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


